Intellectual Property
Feb. 2, 2012
How patent reform will impact biotech
The first-to-file system poses problems for biotech because of patent law's written description requirement. By George Yu of Schiff Hardin LLP
The recently passed and signed Leahy-Smith America Invents Act of 2011 is the most significant change to U.S. patent law in 60 years and one that is poised to have a profound impact on biotechnology - one of the Bay Area's fastest growing economic engines. The Act will change the U.S. patent system from a "first-to-invent" to a modified "first-to-file" system beginning in March 2013. This first-to-file system will significantl...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In